The human KCNQ2 and KCNQ3 genes encode the pore-forming subunits of Kv7.2 and Kv7.3, respectively. These subunits form heteromeric voltage-gated potassium channels that underlie M-current that regulates repetitive neuronal activity. Mutations in KCNQ2 or KCNQ3 that reduce M-current amplitude are responsible for some forms of benign familial neonatal seizure. Kv7.2/Kv7.3 channels are therapeutic targets in seizure, stroke, migraine, dementia, bipolar disorder, anxiety, and neuropathic pain.
Human Kv7.2/Kv7.3 Potassium Channel Cell Line
For pricing information, detailed technical sheets, or to speak with one of our experts, please contact us at 1.877.CRIVER.1 (1.877.274.8371) or by using our online form.
Can't find what you are looking for? Contact us. We are always developing new cell lines and can work with you on custom projects.